Literature DB >> 24432626

[Qilin pills combined with levofloxacin for asthenospermia accompanied with accessory sex gland infection: a clinical observation].

Yong Gao1, Zi Wan2, Xiang-Zhou Sun2, Ya-Feng Liu2, Ya-Dong Zhang2, Bin Ouyang2, Sheng-Fu Chen2, Tao Zheng2, Xin Chen2, Qi-Yun Yang2, Da-Yu Han2, Bing Yao2, Chun-Hua Deng2, Xiang-An Tu2.   

Abstract

OBJECTIVE: To observe the efficacy of the combination of Qilin Pills and levofloxacin in the treatment of asthenospermia accompanied with accessory sex gland infection.
METHODS: We randomly assigned 80 asthenospermia patients with accessory sex gland infection to groups 1 and 2 of equal number, the former treated with Qilin Pills + levofloxacin, and the latter with levofloxacin only. Qilin Pills were administered at the dose of 6 g tid for 30 days, and levofloxacin at the dose of 0.5 g qd for 20 days. We obtained semen parameters, including the percentage of progressively motile sperm and peroxidase-positive white blood cell (WBC) count, before and after medication, and compared the clinical effects between the two groups.
RESULTS: All the patients accomplished the clinical trial. The therapeutic effectiveness rates in improving progressive sperm motility were 60% in group 1 and 17.5% in group 2, with statistically significant differences between the two groups (P < 0.05). As for the peroxidase-positive WBC count in semen, the effectiveness rates were 87.5% and 82.5%, respectively, with no significant differences between the two groups (P > 0.05).
CONCLUSION: For the treatment of asthenospermia accompanied with accessory sex gland infection, Qilin Pills combined with levofloxacin is evidently better than levofloxacin alone in improving sperm motility, and it has no obvious adverse effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24432626

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  1 in total

1.  Qilin pills alleviate oligoasthenospermia by inhibiting Bax-caspase-9 apoptosis pathway in the testes of model rats.

Authors:  Kaishu Zhang; Zhengyan Ge; Longlong Fu; Qi An; Fang Zhou; Ying Guo; Xiaowei Wang; Wenhong Lu; Xiaowei Liang; Shusong Wang; Xuejun Shang; Yiqun Gu
Journal:  Oncotarget       Date:  2018-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.